Union code relating to medicinal products for human use

Vote: Amendment 346 to article 82, paragraph 1, subparagraph 1
Decision: No. 31 of the sitting of 10 Apr 2024
Result: 53 for · 532 against · 14 abstained Rejected · roll call
Date: 10 April 2024, 19:19

More facts (6)

Position: vote 15 of 19 on the decision
Requested by: roll call: ID
Official label: A9-0140/2024 – Pernille Weiss – Article 82, § 1, sub§ 1 – Am 346
Text: Report A-9-2024-0140
Dossier: 2023-0132
Vote id: 167882

Position: vote 15 of 19 on the decision
Requested by: roll call: ID
Official label: A9-0140/2024 – Pernille Weiss – Article 82, § 1, sub§ 1 – Am 346
Text: Report A-9-2024-0140
Dossier: 2023-0132
Vote id: 167882

Cite this page

The members file includes members in office who did not vote.

Roll-call results (EP)

Link to this page

Result

The vote as recorded by name.

Rejected · 9 % of the votes cast were for.

Groups

Members counted in their current group: the view with groups at the date of the vote is not available right now.

Members’ votes by their current group. Majority: the most common position. Clear line: a position with at least two thirds of the group’s votes, otherwise Divided.
Group	For	Against	Abst.	Majority line	Clear line
Patriots	For 17	Against 8	Abst. 1	Majority line For	Clear line Divided
ESN	For 4	Against 0	Abst. 0	Majority line For	Clear line For
ECR	For 2	Against 21	Abst. 1	Majority line Against	Clear line Against
EPP	For 1	Against 79	Abst. 0	Majority line Against	Clear line Against
The Left	For 0	Against 13	Abst. 0	Majority line Against	Clear line Against
Greens	For 0	Against 29	Abst. 0	Majority line Against	Clear line Against
S&D	For 0	Against 59	Abst. 2	Majority line Against	Clear line Against
Renew	For 0	Against 37	Abst. 0	Majority line Against	Clear line Against
No group	For 0	Against 3	Abst. 0	Majority line —	Clear line No line

Countries × groups

How each country’s members of each group voted.

The breakdown by country is not available right now.

Members

Each member’s recorded position — groups as of today: the view with groups at the date of the vote is not available right now.

Show all 599 members

No vote recorded

Members in office that day without a recorded position. No vote recorded is not the same as absent: leave, illness or chairing the sitting look the same.

The list of members without a recorded position is not available right now.

Similar votes

Roll calls that split the chamber the most similarly: r is the correlation of members’ positions, over the members who voted in both. Other votes on the same decision are left out.

Similar votes are not available right now.

Compare with another vote

Groups’ lines side by side, and the members who switched between the two votes.

Connections

This vote’s decision, the other votes on it, and related votes.

No connections found for this vote.

Sources & citation

Where the facts on this page come from, and how to cite it.

Permalink: https://news.eu-parl.st-solutions.dev/votes/2024-04-10/167882
Official sources: Roll-call votes, sitting of 10 April 2024 (European Parliament)
Results of votes, sitting of 10 April 2024 (European Parliament)
Data source: EP Open Data API: vote results of the sitting MTG-PL-2024-04-10
Licensed CC BY 4.0.
Retrieved: 25 September 2026

Cite as

European Parliament (2024). “Amendment 346 to article 82, paragraph 1, subparagraph 1 — Union code relating to medicinal products for human use”. Vote, 10 April 2024. votingId 167882, reference 2023-0132. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/votes/2024-04-10/167882 (retrieved 25 September 2026). Official sources: Roll-call votes, sitting of 10 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-RCV_EN.html; Results of votes, sitting of 10 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-VOT_EN.html. Data: EP Open Data API: vote results of the sitting MTG-PL-2024-04-10, https://data.europarl.europa.eu/api/v2/meetings/MTG-PL-2024-04-10/vote-results?format=application%2Fld%2Bjson (CC BY 4.0).

BibTeX

@misc{epw-vote-2024-04-10-167882,
  author = {{European Parliament}},
  title = {{Amendment 346 to article 82, paragraph 1, subparagraph 1 — Union code relating to medicinal products for human use}},
  year = {2024},
  date = {2024-04-10},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/votes/2024-04-10/167882}},
  url = {https://news.eu-parl.st-solutions.dev/votes/2024-04-10/167882},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Vote. votingId 167882, reference 2023-0132. Official source: https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-RCV\_EN.html, https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-VOT\_EN.html. Data: EP Open Data API: vote results of the sitting MTG-PL-2024-04-10 (CC BY 4.0)}
}